在治疗PARP抑制剂时,POLE3-POLE4的损失会释放复制间隙积累
Bethany Rebekah Hill1, Meryem Ozgencil1, Lauryn Buckley-Benbow1
1Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK.
Cell reports
|May 16, 2024
概括
丢失POLE3-POLE4子单元通过增加复制性差距,使癌细胞对PARP抑制剂 (PARPis) 产生敏感性. 这一发现绕过了常见的抗药性机制,为PARPi抗性癌症提供了新的策略.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- PARP 抑制剂 (PARPis) 对抗 BRCA1/BRCA2 突变癌症是有效的.
- 对PARPis的耐药性是一个重大的临床挑战.
- 了解PARPi敏感性机制对于改善癌症治疗至关重要.
研究的目的:
- 为了研究DNA聚合酶epsilon (Polε) 子单元在PARPi敏感性中的作用.
- 为了确定新的机制,使癌细胞对PARPis.敏感.
主要方法:
- 生成的POLE3-POLE4淘汰赛 (KO) 癌细胞系.
- 在KO细胞中评估PARPi灵敏度.
- 分析了RAD51焦点形成和复制性缺口.
- 研究了PRIMPOL和53BP1.1的作用.
主要成果:
- 丢失POLE3-POLE4亚单元使癌细胞对PARPis敏感,而不依赖于Pole的水平.
- 这种敏感性不是由于同源重组的缺陷 (RAD51焦点).
- 通过PRIMPOL,PARPi治疗诱导了POLE3-POLE4 KO细胞中的复制性缺口.
- 丢失POLE3-POLE4使BRCA1-沉默细胞对PARPis敏感.
- 53BP1的淘汰并不能在POLE3-POLE4 KO细胞中恢复PARPi的敏感性.
结论:
- 丢失POLE3-POLE4子单元代表了一种使癌细胞对PARPis. 敏感的新机制.
- 这一途径绕过了涉及53BP1.1的常见PARPi抵抗机制.
- 针对POLE3-POLE4或相关途径可以在癌症治疗中克服PARPi耐药性.
相关概念视频
02:37Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
02:37DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
01:02Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:23Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
02:10Translesion DNA Polymerases
10.0K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.0K